Showing results (41-50 of 182) with videos related to
Sort By:
Pageof 19
Frontiers in Immunology|August 15, 2022
A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials of Iguratimod Combined With Other Therapies for Sjogren's SyndromeLiuting Zeng, Qi He, Kailin Yang, et al.Frontiers in Pharmacology|April 11, 2024
Advancements in research on the immune-inflammatory mechanisms mediated by NLRP3 inflammasome in ischemic stroke and the regulatory role of natural plant productsKailin Yang, Liuting Zeng, Qi He, et al.Foods (Basel, Switzerland)|December 23, 2023
Huangqin Tea Total Flavonoids-Gut Microbiota Interactions: Based on Metabolome and Microbiome AnalysisYaping Zheng, Kailin Yang, Jie Shen, et al.Nature Reviews. Cancer|June 17, 2022
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneityRyan C Gimple, Kailin Yang, Matthew E Halbert, et al.Molecular and Cellular Biology|April 13, 2011
The USP1/UAF1 complex promotes double-strand break repair through homologous recombinationJunko Murai, Kailin Yang, Donniphat Dejsuphong, et al.Molecular Cell|July 31, 2010
The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint responseMin Huang, Jung Min Kim, Bunsyo Shiotani, et al.Frontiers in Pharmacology|June 30, 2020
Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics MethodologyKailin Yang, Liuting Zeng, Anqi Ge, et al.Frontiers in Immunology|August 18, 2022
Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled TrialsLiuting Zeng, Tiejun Yang, Kailin Yang, et al.Frontiers in Immunology|August 8, 2022
Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled TrialLiuting Zeng, Tiejun Yang, Kailin Yang, et al.Drug Design, Development and Therapy|December 7, 2023
Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota-Gut-Brain AxisHuifang Nie, Jinwen Ge, Kailin Yang, et al.Pageof 19